Luoxin Pharmaceuticals Group Stock Co Ltd Total Assets
Luoxin Pharmaceuticals Group Stock Co Ltd total assets. Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) holds total assets worth CN¥3.61 Billion CNY (≈ $528.95 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 002793 market cap for the company's overall valuation and market capitalisation.
Total Assets of Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
Total assets of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Luoxin Pharmaceuticals Group Stock Co Lt for real-time trading data and today's change.
Luoxin Pharmaceuticals Group Stock Co Ltd - Asset Composition Analysis
Luoxin Pharmaceuticals Group Stock Co Ltd Total Assets Breakdown (December 2025)
Luoxin Pharmaceuticals Group Stock Co Ltd total assets breakdown as of December 2025. Luoxin Pharmaceuticals Group Stock Co Ltd's total assets of CN¥3.61 Billion consist of 51.8% current assets and 48.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.8% |
| Accounts Receivable | CN¥429.32 Million | 11.5% |
| Inventory | CN¥323.62 Million | 8.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥599.46 Million | 16.1% |
| Goodwill | CN¥1.95 Million | 0.1% |
Asset Composition Trend (2011–2025)
This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Luoxin Pharmaceuticals Group Stock Co Lt's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Luoxin Pharmaceuticals Group Stock Co Ltd's current assets represent 51.8% of total assets in 2025, a decrease from 75.2% in 2011.
- Cash Position: Cash and equivalents constituted 14.8% of total assets in 2025, down from 24.0% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 2.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 16.1% of total assets.
Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Total Assets
Key competitors of Luoxin Pharmaceuticals Group Stock Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Luoxin Pharmaceuticals Group Stock Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.79 | 0.74 | 1.73 |
| Quick Ratio | 0.63 | 0.54 | 1.54 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-488.68 Million | CN¥-523.95 Million | CN¥2.63 Billion |
Luoxin Pharmaceuticals Group Stock Co Ltd - Advanced Valuation Insights
This section examines the relationship between Luoxin Pharmaceuticals Group Stock Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.35 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -14.1% |
| Total Assets | CN¥3.73 Billion |
| Market Capitalization | $649.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Luoxin Pharmaceuticals Group Stock Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Luoxin Pharmaceuticals Group Stock Co Ltd's assets decreased by 14.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
The table below shows the annual total assets of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.73 Billion ≈ $545.13 Million |
-14.08% |
| 2024-12-31 | CN¥4.34 Billion ≈ $634.49 Million |
-15.27% |
| 2023-12-31 | CN¥5.12 Billion ≈ $748.84 Million |
-36.88% |
| 2022-12-31 | CN¥8.11 Billion ≈ $1.19 Billion |
-14.63% |
| 2021-12-31 | CN¥9.50 Billion ≈ $1.39 Billion |
+22.99% |
| 2020-12-31 | CN¥7.72 Billion ≈ $1.13 Billion |
+3.50% |
| 2019-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
+432.24% |
| 2018-12-31 | CN¥1.40 Billion ≈ $205.12 Million |
+55.93% |
| 2017-12-31 | CN¥898.93 Million ≈ $131.54 Million |
+10.58% |
| 2016-12-31 | CN¥812.89 Million ≈ $118.95 Million |
+47.91% |
| 2015-12-31 | CN¥549.60 Million ≈ $80.42 Million |
+22.72% |
| 2014-12-31 | CN¥447.86 Million ≈ $65.54 Million |
+23.28% |
| 2013-12-31 | CN¥363.30 Million ≈ $53.16 Million |
-2.42% |
| 2012-12-31 | CN¥372.31 Million ≈ $54.48 Million |
+36.91% |
| 2011-12-31 | CN¥271.94 Million ≈ $39.79 Million |
-- |
About Luoxin Pharmaceuticals Group Stock Co Ltd
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sales of pharmaceutical products in China. The company provides anti-infective active pharmaceutical ingredients(APIs), antiviral APIs, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic… Read more